Current senolytic agents are primarily employed in cancer therapies, such as doxorubicin, trametinib, and cell cycle-targeting drugs like palbociclib (Lea et al., 2022
This ensures that insulin levels from your last meal have returned to baseline, providing a clear window for the peptides to work effectively
Widely used for type 2 diabetes (T2D) and obesity, these agents offer benefits beyond glycemic control, including cardiovascular protection, with emerging evidence suggesting broader metabolic and possible neurocognitive effects
These metabolic improvements may be beneficial, though it's important to note that Zepbound does not have an FDA-approved indication for cardiovascular risk reduction
Sleep is one of the perimenopause symptoms that responds best to medical treatment, and a supplement will not get at the cause
Are you interested in learning more about GLP-1s for weight loss in La Jolla and San Diego